Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 42 min ago
PreprintCC BY-NC-NDmedRxiv

WITHDRAWN: Heterozygous germline MSH3 mutations, and probably MLH3 mutations, act as classical tumour suppressors, leading to excess somatic deletion mutations, signature ID4 and increased colorectal cancer risk

  • I. Soriano
  • K. Sherwood
  • J. C. Ward
  • J. Fernandez-Tajes
  • A. Aman
  • S. Thorn
  • G. Gul
  • J. Wilson
  • A. Isaksson
  • B. Glimelius
  • T. Sjoblom
  • C. Palles
1 more authors
  • I. Tomlinson1
  1. 1University of Oxford
Read full textPDFDOICite

Abstract

Withdrawal statementThis version of the manuscript and associated files have been removed owing to the presence of confidential information. The paper has been published and is available at doi: 10.1136/gutjnl-2026-338390.

Versions

Related

  1. Double heterozygous pathogenic germline APC and MSH2 variants in a 16-year-old female diagnosed with colorectal cancer
    Elena Maccaroni, Riccardo Bacalini, Alessia Lancianese +20
    Familial CancerPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicinePMC
  2. A novel murine colorectal cancer cell line mirroring key clinically relevant mutations
    Maggie L. Lesch, Jiyong Zhao, Taylor P. Uccello +17
    BMC MedicinePeer-reviewedCC BY-NC-ND 4.0OncologyCrossref
  3. Differences in Somatic Mutations Between Early-Onset and Late-Onset Colorectal Cancer: A Systematic Review and Meta-Analysis
    Hui Lionel Raphael Chen, Jun Yan Ian Wee, Jun Kiat Thaddaeus Tan +6
    CancersPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  4. Survival Outcomes in Metastatic Colorectal Cancer Patients with BRAF Mutations Undergoing Targeted Chemotherapy: A Reconstructed Individual Patient Data Meta-Analysis of Randomized Controlled Trials.
    Syeda Kanza Kazmi, Muhammad Abdul Rehman, Hanaa Tariq +3
    Journal of gastrointestinal cancerPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  5. Loss of Ferroptosis-suppressors Accelerates Breast Cancer Recurrence by Promoting Dormancy Exit
    E. K. Shea, M. Lawrence-Paul, A. Sreekumar +7
    bioRxivPreprintAll rights reservedFull textOncologybioRxiv

Cite

BibTeXRIS
BibTeX
@misc{soriano2026withdrawn,
  title = {{WITHDRAWN: Heterozygous germline MSH3 mutations, and probably MLH3 mutations, act as classical tumour suppressors, leading to excess somatic deletion mutations, signature ID4 and increased colorectal cancer risk}},
  author = {I. Soriano and K. Sherwood and J. C. Ward and J. Fernandez-Tajes and A. Aman and S. Thorn and G. Gul and J. Wilson and A. Isaksson and B. Glimelius and T. Sjoblom and C. Palles and I. Tomlinson},
  howpublished = {medRxiv},
  year = {2026},
  month = jul,
  doi = {10.64898/2026.07.22.26358679},
  url = {https://www.medrxiv.org/content/10.64898/2026.07.22.26358679v1},
  note = {CC BY-NC-ND},
}
RIS
TY  - UNPB
TI  - WITHDRAWN: Heterozygous germline MSH3 mutations, and probably MLH3 mutations, act as classical tumour suppressors, leading to excess somatic deletion mutations, signature ID4 and increased colorectal cancer risk
AU  - I. Soriano
AU  - K. Sherwood
AU  - J. C. Ward
AU  - J. Fernandez-Tajes
AU  - A. Aman
AU  - S. Thorn
AU  - G. Gul
AU  - J. Wilson
AU  - A. Isaksson
AU  - B. Glimelius
AU  - T. Sjoblom
AU  - C. Palles
AU  - I. Tomlinson
PY  - 2026
DA  - 2026/07/22
PB  - medRxiv
DO  - 10.64898/2026.07.22.26358679
UR  - https://www.medrxiv.org/content/10.64898/2026.07.22.26358679v1
AB  - Withdrawal statementThis version of the manuscript and associated files have been removed owing to the presence of confidential information. The paper has been published and is available at doi: 10.1136/gutjnl-2026-338390.
ER  -